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Objectives: Apoptosis is a mechanism for deletion of injured or obsolete cells
that is distinct from necrosis and mediated by mitochondrial release of cyto-
chrome c caspase activation. Because myocardial apoptosis is a part of normal
fetal and postnatal maturation, we hypothesize that neonatal myocardium is
more vulnerable to undergo myocardial apoptosis than mature myocardium after
cardioplegic arrest.
Methods: Newborn and mature lambs (n  5 in each group) underwent cardio-
pulmonary bypass, antegrade crystalloid hyperkalemic cardioplegic arrest for 60
minutes, and a 6-hour recovery period. Myocardium was examined by using
terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate–
digoxigenin nick end labeling (TUNEL), Western blotting, in vitro kinase
assays, and fluorometric assays of the activity of caspases 3, 8, and 9. Myocar-
dium from nonoperated control subjects (n  5 in each age group) was also
obtained.
Results: More TUNEL-positive nuclei were present in the newborn postcar-
dioplegic myocardium (P  .04). Caspase 3, 8, and 9 activities were 1.6-fold,
1.5-fold, and 1.4-fold greater in the newborn postcardioplegic myocardium (P 
.04, P  .01, and P  .01, respectively). The Bax/Bcl-2 ratio was higher in the
newborn postcardioplegic myocardium (P  .04). Apoptosis signal-regulating
kinase 1 activity and cleaved caspase 3 levels were higher in the newborn
postcardioplegic myocardium (P  .02 and P  .009). Mitochondrial release of
cytochrome c was greater in the newborn postcardioplegic myocardium (P 
.009).
Conclusions: The increased Bax/Bcl-2 ratio in the newborn myocardium sug-
gests a proapoptotic state that is manifested by greater TUNEL staining, cyto-
chrome c release, and cleavage of caspase 3. Increased apoptosis signal-regu-
lating kinase 1 activity suggests greater oxidative stress, immature mechanisms
to ameliorate oxidative stress, or both in the neonatal myocardium. Mitochon-
drial release of cytochrome c suggests that apoptosis-related mitochondrial
dysfunction might contribute to early postoperative myocardial dysfunction in
the neonate.
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Cardiac surgery in the neonate is frequentlyfollowed by early postoperative myocar-dial dysfunction. This myocardial dysfunc-tion typically peaks at 6 to 12 hours afterthe operation and improves thereafter.1,2Although postoperative dysfunction in
general has been ascribed to myocardial stunning, the rela-
tionship between classical models of stunning and the “mid-
night sag” has not been clearly defined.
In addition to myocardial stunning, the neonatal heart
might be uniquely vulnerable to initiation of apoptosis in the
early postoperative period for the following reasons. First,
neonatal hearts activate apoptosis pathways as a normal part
of postnatal myocardial remodeling.3 Second, cardiopulmo-
nary bypass causes a systemic increase of proapoptotic
factors (eg, tumor necrosis factor ).4 Finally, the ischemia-
reperfusion injury associated with cardioplegic arrest might
initiate apoptosis.5 In addition, the time course of the mito-
chondrial dysfunction associated with apoptosis coincides
with the time course of the midnight sag.6 Consequently, we
hypothesize that activation of apoptosis-related mechanisms
is an important consequence of cardiac surgery in the neo-
nate. Because activation of apoptosis is intimately associ-
ated with release of cytochrome c from the mitochondria
and diminished mitochondrial energy production,7 apopto-
sis-related processes might contribute to the clinical obser-
vation of decreased myocardial function in the early post-
operative period.2
In this study we explored age-related differences in the
myocardial response to cardiopulmonary bypass and car-
dioplegic arrest in a clinically relevant sheep model. Spe-
cifically, we seek to compare the balance between proapop-
totic and antiapoptotic mediators in the neonatal and mature
myocardium, as well as to demonstrate the association be-
tween the proapoptotic state and the apoptosis-related man-
ifestations of cardioplegic arrest and 6 hours of reperfusion.
We hypothesize that the proapoptotic state of the new-
born myocardium will lead to greater activation of apo-
ptosis mediators, more extensive apoptosis-related mito-
chondrial alterations, and a greater proportion of




Six- to 8-day-old lambs (newborn group, n  5) and 6- to 8-week-
old lambs (mature group, n  5) were anesthetized with intrave-
nous sodium pentothal, intubated orotracheally, and maintained
with inhalational general anesthesia for the duration of the exper-
iment. Through a median sternotomy, right atrial and aortic can-
nulas were placed, and cardiopulmonary bypass was initiated with
a blood prime and passive cooling to a core temperature of 28°C
to 30°C. The ductus arteriosis was ligated if patent. The aorta was
then crossclamped, and cold Plegisol (Abbott’s cardioplegic solu-
tion: Na, 110 mEq/L; Cl, 160 mEq/L; K, 16 mEq/L; Ca, 2.4
mEq/L; Mg, 32 mEq/L; pH 7.8) was delivered at 4°C into an aortic
root needle with 50 to 70 mm Hg of perfusion pressure to a total
initial dose of 20 mL/kg body weight. Subsequent cold cardiople-
gia doses of 15 mL/kg were delivered at 20-minute intervals.
Between cardioplegia doses, topical cooling was applied, and the
aortic root and pulmonary artery were vented. After 60 minutes of
arrest, the crossclamp was removed, the animal was rewarmed,
and, after a 10- to 20-minute stabilization period, bypass was
terminated, heparin was reversed with protamine, and the perfu-
sion cannulas were removed.
General anesthesia was maintained for 6 hours after reperfu-
sion, during which time arterial blood gases, electrolytes, and
hematocrit levels were maintained in a physiologic range, and
maternal blood or crystalloid was infused as necessary to maintain
arterial pressure. Inotropic agents were not administered. After 6
hours, the heart was quickly excised and perfused through the
coronary arteries with 240 mL of ice-cold Dulbecco’s phosphate-
buffered saline. Full-thickness left ventricular free wall was
minced and snap-frozen in liquid nitrogen and then stored at
80°C. Nonoperated animals for each age group were anesthe-
tized, and cardiectomy was performed shortly afterward
through a median sternotomy. Tissue samples were treated in
the same fashion as experimental groups. All animals appropri-
ately received humane care in compliance with the “Guide for
the Care and Use of Laboratory Animals” prepared by the
Association for Assessment and Accreditation of Laboratory
Animal Care (March 1999).
Tissue Samples
Immediately after death, myocardial tissue samples (approxi-
mately 1.0  1.5 mm each) were sliced, snap-frozen in liquid
nitrogen, and stored at 80°C for Western blotting and enzymatic
studies. Other tissues were fixed fresh in 10% formaldehyde over-
night and subsequently embedded in paraffin for terminal deoxy-
nucleotidyl transferase–mediated deoxyuridine triphosphate–
digoxigenin nick end labeling (TUNEL) study.
Tissue Fractionation for Biochemical Analysis
Approximately 200 mg of frozen left ventricular myocardial sam-
ples were mechanically homogenized with Dounce homogenizer
in ice-cold isotonic buffer (250 mmol/L sucrose, 20 mmol/L N-2-
hydroxyethylpiperazine-N-2-ethanesulfonic acid, 10 mmol/L KCl,
1.5 mmol/L MgCl2, 1 mmol/L ethylenediamine tetraacetic acid, 1
mmol/L ethyleneglycol-bis-[-aminoethylether]-N,N,N',N'-tet-
raacetic acid, 1 mmol/L dithiothreitol [DTT], 17.4 g/mL phenyl-
methylsulfonyl fluoride [PMSF], 8 g/mL aprotinin, and 2 g/mL
leupeptin [pH 7.4]). The cells were lysed by using 10 loose and
then 10 tight strokes in an ice-cold cylinder Dounce homogenizer.
Unlysed cells and nuclei were removed by means of centrifugation
at 750g for 5 minutes at 4°C. The supernatant was spun at 10,000g
for 25 minutes at 4°C, and the resulting mitochondrial pellets were
then resuspended in the above buffer and frozen in multiple
samples at 80°C. The supernatant was centrifuged at 100,000g
for 1 hour at 4°C. The supernatant of this final centrifugation,
representing the cytosolic fraction, was divided into aliquots and
stored at 80°C for future analysis.
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TUNEL was performed with a modification of the technique
described by Olivetti and colleagues8 by using the ApopTag In-
Situ kit (Intergen). Briefly, 5-m cryostat sections were fixed with
freshly prepared 10% formaldehyde at room temperature overnight
and then paraffinized. The TUNEL assay was performed in 5-m-
thick deparaffinized sections. Four 5-m sections were preincu-
bated with equilibration buffer for 5 minutes and subsequently
incubated with deoxyribonucleotidyl transferase in the presence of
digoxigenin-conjugated deoxyuridine triphosphate for 1 hour at
37°C. The reaction was terminated by incubating the samples in
stopping buffer and then with the fluorescein-labeled antidigoxi-
genin antibody (yellow-green). Cell nuclei were counterstained
with DAPI (Vector Laboratories). Ten random high-power fields
representing approximately 4000 cells were counted to enumerate
TUNEL-positive cells. Formalin-fixed and paraffin-embedded
5-m sections were stained with mouse monoclonal IgM anti--
sarcomeric actin antibody (Sigma) and Alexa Fluor 594-conju-
gated goat anti-mouse IgM (Molecular Probes) and then TUNEL
stained as above to identify cell type. Adjacent sections were
stained with hematoxylin and eosin and examined by means of
light microscopy for evidence of necrosis.
Caspase Activity Assay
A fluorometric caspase activity assay was performed as previously
described.9 Snap-frozen left ventricular myocardial samples were
homogenized in cold detergent buffer (10 mmol/L Tris-HCl, pH
8.0; 1% Triton X-100; 0.32 mol/L sucrose; and 5 mmol/L ethyl-
enediamine tetraacetic acid) with proteinase inhibitors (1 mmol/L
PMSF, 2 mmol/L DTT, 10 g/mL leupeptin, and 10 g/mL
aprotinin) and cellular debris pelleted at 13,000g for 10 minutes at
4°C. Supernatant protein concentration was standardized on the
basis of chromogenic assay (Bio-Rad). Samples were diluted in
assay buffer (10% sucrose; 100 mmol/L N-2-hydroxyethylpipera-
zine-N-2-ethanesulfonic acid, pH 7.5; 100 mmol/L NaCl; and
0.1% CHAPS) with proteinase inhibitors as above. Tetrapeptide
substrates of caspase 3 (Ac-DEVD-AFC), caspase 8 (CBZ-IETD-
AFC), and caspase 9 (Ac-LEHD-AFC; all from Sigma) were
added (50 mol/L), and the fluorescence before and after 1 hour of
incubation at 37°C were measured with a PerkinElmer LM50B
fluorometer (EG&G) and compared with a curve of known con-
centrations diluted in each sample.
Citrate Synthase Activity
Citrate synthase activity was determined by using acetyl coenzyme
A solution (12.5 mmol/L, pH 5) and oxaloacetic acid solution
(OAA; 10 mmol/L) with 5,5'-dithio-bis(2-nitrobenzoic acid) solu-
tion (1 mmol/L in 1 mol/L Tris-HCl, pH 8.1) as a reporting
molecule. A quantity of 10 L of cytosolic protein was incubated
with 810 L of ddH20, 100 L of 1 mmol/L 5,5'-dithio-bis(2-
nitrobenzoic acid), and 30 L of acetyl coenzyme A. The rate
before the addition of OAA was measured for 2 minutes by using
a kinetics program in conjunction with a Beckman Spectropho-
tometer, with an absorption wavelength set at 405 nm. After 2
minutes, 50 L of OAA was added, and the activity was then
measured as a difference in rates before and after OAA addition.
Citrate synthase activity was calculated by dividing this number by
the protein concentration.
Western Blotting for Cytochrome c, Bax, Bcl-2, Bcl-xL,
and Caspase 3
Homogenized samples standardized for protein content were sub-
jected to sodium dodecylsulfate–polyacrylamide gel electrophore-
sis on 15% linear gradient gels and subsequently transferred to
nitrocellulose membranes. The membrane was probed for cyto-
chrome c with monoclonal anti-mouse cytochrome c antibody (BD
Biosciences Pharmingen). The membrane was probed for Bax,
Bcl-2, and Bcl-xL with anti-mouse IgG monoclonal antibodies
(Santa Cruz Biotechnology). For quantitation of total and cleaved
caspase 3, the membrane was probed with rabbit anti-human
caspase 3 antibody (New England Biolabs Inc). Secondary anti-
bodies were coupled to horseradish peroxidase (anti-mouse IgG–
horseradish peroxidase, Upstate Biotechnology; anti-rabbit IgG–
horseradish peroxidase, Santa Cruz Biotechnology). The resulting
autoradiographs were scanned and quantified with a densitometer
(National Institutes of Health image software).
Measurement of Apoptosis-regulating Kinase 1
Activity
Left ventricular myocardium was homogenized on ice in cell lysis
buffer (50 mmol/L Tris-HCl [pH 7.5], 150 mmol/L NaCl, 10
mmol/L ethylenediamine-N',N',N',N'-tetraacetic acid, 0.2 mmol/L
DTT, 200 g/mL leupeptin, 20 g/mL aprotinin, and 1 mmol/L
PMSF). After incubation at 4°C for 30 minutes, the homogenates
were sonicated on ice for 1 minute and then centrifuged at 15,000
rpm at 4°C for 30 minutes. After centrifugation, the supernatants
were stored at 80°C until later use. Triton X-100 (1% final
concentration) was added to protein extracts (50 g), followed by
incubation with antibody against apoptosis-regulating kinase 1
(ASK-1; pc rabbit, Santa Cruz Biotechnology). The immune com-
plex was precipitated with protein A agarose at 4°C for 1 hour. The
precipitated ASK-1 was washed 3 times with 20 mmol/L Tris-HCl
(pH 7.5) buffer containing 150 mmol/L NaCl, 5 mmol/L bis-
N,N,N',N'-tetraacetic acid, 2 mmol/L DTT, and 1 mmol/L PMSF
and once with a reaction buffer of 20 mmol/L Tris-HCl (pH 7.5)
and 20 mmol/L MgCl2. The reaction was carried out in the reaction
buffer in the presence of 0.5 Ci of phosphorous 32–labeled
adenosine triphosphate (ATP; PerkinElmer Life Sciences) and 1
mmol/L ATP for 30 minutes at 30°C by using myelin basic protein
(40 g/mL, Sigma) as exogenous substrate. The phosphorylated
proteins were separated by using 15% sodium dodecylsulfate–
polyacrylamide gel electrophoresis and visualized with autora-
diography. The resulting images were scanned and analyzed with
National Institutes of Health image software.
Statistical Analysis
Data are presented as means  SEM, and comparisons between
the 2 main groups and subgroups were made by using analysis of
variance, followed by the Student t test.
Results
TUNEL
The number of TUNEL-positive nuclei in left ventricular
sections after cardioplegia is depicted in Figure 1. There
were 3.4  1.6 positive nuclei per high-power field in the
newborn cardioplegia group (representing approximately
Surgery for Congenital Heart Disease Karimi et al
492 The Journal of Thoracic and Cardiovascular Surgery ● February 2004
CH
D
0.82% of cells) compared with 1.3  1.0 per high-power
field in mature cardioplegic lambs (P .04). There were no
TUNEL-positive nuclei in the nonoperated groups (results
not shown). Labeling with TUNEL, DAPI, and actin im-
munofluorescence showed that nearly all TUNEL-positive
nuclei appeared in actin-containing cells, indicating cardio-
myocyte apoptosis. Adjacent sections stained with hema-
toxylin and eosin showed no evidence of necrosis (results
not shown).
Caspase Activity
Caspase 3–, 8–, and 9–like activities are shown in Figure 2.
Six hours after cardioplegia, caspase 3, 8, and 9 activities
were 1.6-fold, 1.5-fold, and 1.4-fold greater in neonates (P
 0.04, P  .01, and P  .01, respectively) than in mature
cardioplegic lambs.
Caspase 3 Western Blotting
Western blot analysis showed a significant increase in the
concentration of cleaved caspase 3 (the active form) in the
neonatal cardioplegic group compared with that in the ma-
ture cardioplegic group (26.6  4.3 AU vs 6.05  3.2 AU,
P  .009). There were no significant differences in total
caspase 3 (inactive form) levels between the 2 groups (124.3
 10.4 AU vs 125.8  6.8 AU, P  .91, Figure 3).
Cytosolic Cytochrome c Western Blotting
After subcellular fractionation, Western immunoblot analy-
sis for cytosolic cytochrome c revealed higher concentra-
tions of cytosolic cytochrome c in the newborn cardioplegic
group compared with in the mature cardioplegic group.
These data were normalized to citrate synthase activity,
which was used to correct for artifactual disruption of the
mitochondria during the tissue preparation process. After
normalization, the cytosolic cytochrome c concentration
was greater in the newborn cardioplegic group than in the
mature cardioplegic group (146.2 24 AU · U1 · mg1 vs
Figure 1. The number of TUNEL-positive nuclei per high-power
field in left ventricular myocardium after cardioplegia in newborn
(nb-cp) and mature (mt-cp) lambs. Cryostat sections were stained
by using TUNEL and counterstained with DAPI. Fluorescent nu-
clei in 10 random high-power fields per section were manually
counted. TUNEL positivity in newborns was significantly greater
than in mature cardioplegic lambs. All results are shown as
means  SEM (n  5 for each sample). *Significant difference at
a P value of less than .05.
Figure 2. Hydrolytic activity for specific tetrapeptide substrates
of caspases 3, 8, and 9 in total cellular protein from left ventric-
ular myocardium of newborn (nb-cp) and mature (mt-cp) car-
dioplegic lambs. Activity is expressed graphically as the ratio of
activity in newborn to mature protein extracts for each caspase.
All results are shown as means  SEM (n  5 for each sample).
*Significant difference at a P value of less than .05.
Figure 3. Western blot densitometric measurements of total
caspase 3 and cleaved caspase 3 in the mature cardioplegic
(mt-cp) group versus the newborn cardioplegic (nb-cp) group.
Representative Western immunoblots for each group are shown
above each bar graph. All results are shown as means  SEM (n
 5 for each sample). *Significant difference at a P value of less
than .05.
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74.5  5.6 AU · U1 · mg1, P  .009; Figure 4, A). Our
measurements displayed some citrate synthase activity in all
cytosolic preparations ranging between 0.46 and 3.97 U/mg
protein. We also used cytochrome c oxidase subunit IV
(Cox-4) as another indicator of mitochondrial membrane
disruption during tissue homogenization. Western blotting
of the cytosolic fraction failed to show the presence of
Cox-4 for all groups, indicating the relative purity of the
tissue fractions (results not shown). Greater concentration of
cytosolic cytochrome c normalized to citrate synthase ac-
tivity was found in the newborn cardioplegic group when
compared with that seen in newborn nonoperated animals
(58.3  7.9 AU · U1 · mg1 vs 26.4  5.5 AU · U1 ·
mg1, P  .01; Figure 4, B). In contrast, there were no
significant differences in the cytosolic cytochrome c release
in the mature cardioplegic group when compared with that
in the mature nonoperated animals (26.7  10.4 AU · U1
· mg1 vs 22.04  4.6 AU · U1 · mg1, P  .68; Figure
4, C).
Bax and Bcl-2 Western Blotting
The densitometric data of the Western blotting for Bax and
Bcl-2 revealed a higher concentration of Bax protein in the
newborn cardioplegic group in comparison with that found
in the mature cardioplegic group (108  10.3 vs 78  6.8
AU, P  .04). There were no statistically significant differ-
ences in the amount of Bcl-2 for either group (88.9 6.5 vs
89  3.9 AU, P  .98). Therefore the Bax/Bcl-2 ratio, a
measure of proapoptotic state, was greater in the newborn
heart compared with that in the mature heart after cardiople-
gic arrest (1.22 0.1 vs 0.88 0.09, P .04; Figure 5, A).
Although higher in the neonatal hearts, the Bax/Bcl-2 ratio
was not different when comparing nonoperated groups
(1.50  0.13 vs 1.22  0.01, P  .12; Figure 5, B).
Bcl-xL Western Blotting
The densitometric data of the Western blot for Bcl-xL re-
vealed a higher concentration of the protein in the newborn
cardioplegic group in comparison with that in the mature
cardioplegic group (94.7  6.3 AU vs 48.6  5.1 AU, P 
.0006; Figure 6, A). There were no statistically significant
differences in the amount of Bcl-xL for nonoperated new-
born and mature groups (72.5  6.4 AU vs 57.1  6.4 AU,
P  .08; Figure 6, B).
Activation of ASK-1
ASK-1 activity, a measure of oxidative stress, was greater in
the newborn cardioplegic group compared with in the ma-
ture cardioplegic group, as measured with an in vitro kinase
assay (115.1  5.3 AU vs 90.4  6.2 AU, P  .02, Figure
7).
Discussion
Morphologic, histochemical, and biochemical evidence for
the early stages of myocyte apoptosis arising during the
course of cardiac surgery have been reported in myocardial
samples after cardioplegic arrest and reperfusion in the
human heart.10 Our previous study showed that myocyte
apoptosis was detectable in the left ventricle of the neonatal
lamb heart after cardioplegic arrest and reperfusion demon-
strated on the basis of TUNEL positivity and DNA ladder-
ing.11 In the present study results from TUNEL suggest a
greater degree of myocardial apoptosis after cardioplegic
Figure 4. Western blot densitometric measurements of cytosolic
cytochrome c normalized to citrate synthase for mature (mt) and
newborn (nb) myocardium harvested from nonoperated (nl) and
postcardioplegia (cp) hearts. Representative Western immuno-
blots for each comparison are shown above the bar graph. All
results are shown as means  SEM (n  5 for each comparison).
*Significant difference at a P value of less than .05.
Figure 5. Western blot densitometric measurements of Bax/Bcl-2
ratio for the mature cardioplegic (mt-cp) versus newborn car-
dioplegic (nb-cp) groups (A) and mature nonoperated (mt-nl)
versus newborn nonoperated (nb-nl) groups (B). Representative
Western immunoblots for each group are shown above each bar
graph. All results are shown as means  SEM (n  5 for each
sample). Significant difference at a P value of less than .05.
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arrest in the neonatal lamb compared with in more mature
lambs.
Caspase 8 is an upstream caspase that transduces pro-
apoptotic signals from the cell-surface death receptor com-
plex in response primarily to inflammatory triggers, such as
tumor necrosis factor , which has been shown to be in-
creased after cardiopulmonary bypass.12 Caspase 9, also an
upstream caspase, is activated after mitochondrial release of
cytochrome c in response to oxidative stress after ischemia-
reperfusion injury. Caspase 3, an effector caspase, can be
activated through both the above pathways, resulting in the
activation of a variety of enzymes and feedback loops and
subsequent completion of cell death. In the present study we
found that the activities of all 3 caspases were higher in the
newborn myocardium than in the mature myocardium after
cardioplegic arrest and reperfusion. The difference in
caspase activity between newborns and mature lambs after
the same surgical procedure therefore might reflect either a
difference in activation after cardioplegic arrest or a more
proapoptotic status of the newborn myocardium.
The release of cytochrome c from mitochondria is central
to all forms of apoptosis, resulting in the downstream acti-
vation of effector caspases (ie, caspase 3).13 Cytochrome c
release is known to be regulated by Bcl-2 family proteins.14
Antiapoptotic members of this family, including Bcl-2 and
Bcl-xL, bind to the mitochondrial outer membrane and in-
hibit the release of cytochrome c from the mitochondria. In
contrast, proapoptotic members of the Bcl-2 family, such as
Bax, promote the release of cytochrome c and other mito-
chondrial intermembrane proteins.15 The release of cyto-
chrome c into the cytoplasm has been widely reported in
multiple studies as an irrevocable commitment to cell
death.16-19 In contrast, some recent studies have demon-
strated that the release of cytochrome c does not invariably
lead to apoptotic cell death.20
The greater Bax/Bcl-2 ratio in the neonatal cardioplegic
group suggests that the neonatal hearts are in a more pro-
apoptotic state. The lack of change in the Bax/Bcl-2 ratio
when comparing the nonoperated and postoperative states,
however, suggests that expression of Bax at the protein level
is not upregulated within the early postoperative period,
which is consistent with our previous report that Bax ex-
pression at the mRNA level was not upregulated in response
to cardioplegic arrest in the neonate.12 Nevertheless, these
data do not exclude the possibility of Bax participation in
the mediation of cytochrome c release in this model through
translocation from the cytosol to the mitochondrial mem-
brane without mRNA or protein synthesis.21-23
Bcl-2 and Bcl-xL inhibit the oligomerization of Bax and
prevent apoptosis by preserving mitochondrial integrity and
suppressing cytochrome c release without ameliorating ATP
depletion.18 As our data demonstrate, there were no differ-
ences in the level of Bcl-2 in either group. In contrast,
however, we have found higher levels of Bcl-xL proteins in
the newborn cardioplegic group compared with in their
mature counterparts. This suggests that the newborn myo-
cardium has increased levels of antiapoptotic factors (eg,
Bcl-xL) despite being in the proapoptotic state (higher Bax/
Bcl-2 ratio). Despite increased levels of Bcl-xL, however,
cytochrome c is released within 6 hours from the mitochon-
dria of the postcardioplegic neonatal lamb.
Figure 7. In situ kinase activity for ASK-1 in the mature cardiople-
gic (mt-cp) group versus the newborn cardioplegic (nb-cp) group.
Representative Western immunoblots for each group are shown
above the bar graph. All results are shown as means  SEM (n
 5 for each sample). *Significant difference at a P value of less
than .05.
Figure 6. Western Blot densitometric measurements of Bcl-xL for
newborn cardioplegic (nb-cp) versus mature cardioplegic (mt-cp)
groups (A) and newborn nonoperated (nb-nl) versus mature non-
operated (mt-nl) groups (B). Representative Western immunoblots
for each group are shown above each bar graph. All results are
shown as means  SEM (n  5 for each sample). *Significant
difference at a P value of less than .05.
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Reactive oxygen species are critical signaling molecules
in regulating growth, survival, and death pathways. In the
cardiovascular system significant amounts of reactive oxy-
gen species are generated as byproducts of mitochondrial
metabolism and might increase to toxic levels in the myo-
cardium during and after periods of ischemia.24 ASK-1 is a
member of the mitogen-activated protein kinase kinase ki-
nase family, which is activated in response to cytokines,
oxidants, and stress signals. It is also an upstream activator
of p38 mitogen-activated protein kinases and c-Jun NH2-
terminal kinase, contributing a pivotal signaling pathway in
apoptosis.25,26 Under resting conditions, ASK-1 exists in the
cytosol bound to a small redox-sensitive protein, thiore-
doxin. In the presence of oxidative stress, oxidation of
thioredoxin results in dissociation from ASK-1, leaving
ASK-1 in its active form.27 This study has demonstrated
greater ASK-1 activity in the neonatal cardioplegic group,
suggesting greater dissociation of thioredoxin from ASK-1
caused by the greater presence of oxygen free radicals or
diminished ability to ameliorate free radical injury in the
neonatal hearts. Oxidative stress might be an important
initiating event in the induction of neonatal myocardial
apoptosis.28,29
These data support a profile of increased vulnerability of
the neonate to apoptosis-related processes in the early post-
operative period by using a clinically relevant model of
cardioplegic arrest. The mitochondrial release of cyto-
chrome c suggests the possibility that, in addition to clas-
sical myocardial stunning, apoptosis-related mitochondrial
dysfunction might contribute to the midnight sag frequently
noted after neonatal cardiac surgery. Consequently, rede-
sign of presently available myoprotective strategies might
allow improved preservation of mitochondrial integrity in
the postoperative neonatal heart.
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Discussion
Dr Ralph J. Damiano, Jr (St Louis, Mo). You have beautifully
shown that in the newborn hearts you had more apoptosis, but it is
possible that they are maybe just more apoptotically active. What
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data do you have to say that they are more vulnerable to apoptosis
than a mature model? Do you follow me? You could have apo-
ptosis, but if it was tolerated physiologically, I think that is an
important differentiation. And how would you answer that, and
what data do you have to suggest that it is actually more vulnerable
to apoptosis?
Dr Mohsen Karimi (Iowa City, Iowa). That is an excellent
question. We know that neonates are vulnerable to apoptosis
because it is part of their normal development. We have demon-
strated previously that they became more proapoptotic after car-
dioplegic arrest when you even compare them with neonates
undergoing only cardiopulmonary bypass without cardioplegic
arrest.
Our final discussion slide also proves the above point that
neonatal lambs underwent more apoptosis as the result of car-
dioplegic arrest even when compared with the mature operated
lambs and nonoperated groups. As you see on this slide, the
concentrations of cytosolic cytochrome c were the same for both
the mature cardioplegic and mature nonoperated groups. But when
you compare the newborn cardioplegic versus newborn nonoper-
ated groups, there was significantly higher cytochrome c release in
the newborns that underwent cardioplegic arrest. This basically
demonstrates that neonatal cardioplegic groups are undergoing
more apoptosis than the nonoperated neonate.
Dr Frank W. Sellke (Boston, Mass). Is all of the cytosolic
cytochrome released from apoptosis, or is there a component to
necrosis causing this?
Dr Karimi. We think it is from apoptosis. We have hematox-
ylin and eosin staining from our sections that did not demonstrate
any necrotic histology.
Dr Sellke. Your first statement in your conclusion was that the
Bax/Bcl-2 ratio is the cause for this differential effect between the
mature and the immature hearts, yet the slide that demonstrated the
comparison between the neonatal and the mature heart before and
after cardioplegia had a similar trend in the mature and immature
heart. If you had increased the numbers, I suspect that both of these
would be statistically significant.
Dr Karimi. That is a true statement. The presence of a higher
Bax/Bcl-2 ratio in neonates might or might not contribute to this
process of apoptosis, but there are other proapoptotic factors, such
as Bid, truncated Bid, and Bad, which we are actively investigat-
ing.
Dr Antonio F. Corno (Lausanne, Switzerland). When we
study the effects of ischemia and reperfusion on the myocardium,
I am sure you are aware that we should evaluate all the compo-
nents not only during ischemia, including the type of myocardial
protection, duration of cardioplegia, type of components, cardio-
plegia pressure and volume infusion, and so forth, but even during
the reperfusion, the controlled versus noncontrolled reperfusion.
How did you consider all these variables in your protocol?
What is the rationale to study the status of myocardium after a
period of 6 hours of recovery instead of at the end of reperfusion?
Dr Karimi. I am sorry, but there was a lot of echo. I could not
get the first question, sir.
Dr Corno. How did you evaluate all the variables during
ischemia and during reperfusion in terms of type of myocardial
protection and type of reperfusion in your protocol?
Dr Karimi. If I understand the question well, you are asking
how we differentiate between myocardial ischemia before reper-
fusion or after reperfusion. Is that what you are asking?
Dr Corno. You compared the neonatal hearts with the mature
myocardium, and we know that there is a huge difference between
the two. You used the same type of myocardial protection for both,
knowing that there is a difference. Do you think this is important
in the results you have seen?
Dr Karimi. Yes, it is important.
Dr Corno. Second question. Why did you decide to study the
myocardium after a period of 6 hours of recovery instead of
studying the effects at the end of reperfusion? Why did you leave
a 6-hour recovery?
Dr Karimi. We tried to do 6 hours to simulate what is out in
the real clinical scenario. The neonatal heart function usually
deteriorates after 6 to 12 hours from the operation, and we tried to
create the same clinical scenario.
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